Search

Home > Lung Cancer Considered > FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC
Category: Science & Medicine
Duration: 00:42:03
Publish Date: 2023-11-06 13:57:32
Description: In this podcast, host Dr. Stephen Liu moderates a discussion a recent FDA approval and a specific molecular subtype of NSCLC. On October 11, 2023, the US FDA granted approval to encorafenib and binimetinib for advanced NSCLC harboring a BRAF V600E mutation based on the phase II PHAROS trial.
Total Play: 0